Alnylam Pharmaceuticals, Inc. ALNY

Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200

GlobeNewswire Inc. · 1d ago

Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand

GlobeNewswire Inc. · 4d ago

Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider

GlobeNewswire Inc. · 12d ago

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.

The Motley Fool · 17d ago

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

GlobeNewswire Inc. · 61d ago

Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

GlobeNewswire Inc. · 65d ago

The $3B Biotech With Two Shots On Goal

Benzinga · 124d ago

BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz

Benzinga · 130d ago

Tenaya Therapeutics Stock Jumps After New Alnylam Deal

Benzinga · 135d ago

Amyloidosis Therapeutic Market to Worth Over US$ 6.37 Billion by 2033 | Astute Analytica

GlobeNewswire Inc. · 178d ago

Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale

Benzinga · 187d ago

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

GlobeNewswire Inc. · 193d ago

This AI Infrastructure Stock Is 'Most Likely' To Be Added To S&P 500 In Q1 2026 According To Prediction Markets

Benzinga · 198d ago

Annual Changes to the Nasdaq-100 Index®

GlobeNewswire Inc. · 218d ago

Is Alnylam Pharmaceuticals a Millionaire Maker?

The Motley Fool · 224d ago

What's Going On With Alnylam Stock On Friday?

Benzinga · 232d ago

Backdoor AI Beneficiary Yields 8.8%, Trades at 13% Discount

Investing.com · 235d ago

Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker

Benzinga · 248d ago

New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline

GlobeNewswire Inc. · 257d ago

BlackRock Fund Dividend Reset Offers 9.2% Yield at a Discount

Investing.com · 305d ago

Scenic Biotech Appoints Dr. Roland W. Bürli as CSO to Advance Pipeline of Modifier Therapies in Neuro- and Metabolic Diseases

GlobeNewswire Inc. · 313d ago

Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

GlobeNewswire Inc. · 322d ago

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

GlobeNewswire Inc. · 322d ago

Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis

GlobeNewswire Inc. · 327d ago

Vir (VIR) Q2 Revenue Drops 61%

The Motley Fool · 346d ago